Description

6-Methyl-9-(2-C-Methyl-β-D-Ribofuranosyl) Purine is a high-purity nucleoside analog of significant interest in advanced pharmaceutical research and development. This compound serves as a critical building block for the synthesis of novel antiviral and anticancer agents, offering researchers a pathway to modulate biological activity. It is primarily utilized by R&D laboratories and pharmaceutical manufacturers focused on nucleoside-based therapeutics, where precise molecular structure and purity are paramount for successful outcomes.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the development of nucleoside analog drugs targeting viral infections and oncology.
• Antiviral Drug Research: Used in the discovery and synthesis of potential antiviral compounds, particularly for RNA viruses.
• Oncology Research: Serves as a scaffold for creating novel chemotherapeutic agents that interfere with DNA/RNA synthesis in cancer cells.
• Biochemical Tool Compound: Employed in enzymatic studies and as a probe to investigate purine metabolism and related cellular pathways.
• Process Chemistry & Scale-up: Used in process development for the commercial-scale manufacturing of active pharmaceutical ingredients (APIs).
• Academic & Institutional Research: A valuable reagent for universities and research institutes exploring nucleotide chemistry and medicinal chemistry.

Basic Information

Product Name	6-Methyl-9-(2-C-Methyl-β-D-Ribofuranosyl) Purine
CAS No.	2095417-06-2
Molecular Formula	C12H16N4O4
Molecular Weight	280.28 g/mol
Synonyms	6-Methyl-9-(2-C-methyl-β-D-ribofuranosyl)purine; 2'-C-Methyl-6-methylpurine ribonucleoside; 6-Methyl-2'-C-methyladenosine analog; 9-[(2R,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-2-methyloxolan-2-yl]-6-methylpurine; 2'-C-Methyl-6-methylpurine riboside; 6-Methyl-2'-methyladenosine derivative; Purine nucleoside analog 2095417-06-2
EINECS	Contact for details

Quality Control

Our 6-Methyl-9-(2-C-Methyl-β-D-Ribofuranosyl) Purine is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research and development applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We support compliance with relevant guidelines for pharmaceutical intermediates, and specifications can be aligned with customer-specific requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Purity (HPLC, Area %)	≥ 98.5%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.